107 related articles for article (PubMed ID: 20599831)
1. Rat brain CYP2B induction by nicotine is persistent and does not involve nicotinic acetylcholine receptors.
Khokhar JY; Miksys SL; Tyndale RF
Brain Res; 2010 Aug; 1348():1-9. PubMed ID: 20599831
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic and muscarinic acetylcholine receptors are essential for the long-term response of tyrosine hydroxylase gene expression to chronic nicotine treatment in rat adrenal medulla.
Yoshimura R; Xu L; Sun B; Tank AW
Brain Res Mol Brain Res; 2004 Jul; 126(2):188-97. PubMed ID: 15249143
[TBL] [Abstract][Full Text] [Related]
3. Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects.
Khokhar JY; Tyndale RF
Neuropsychopharmacology; 2011 Feb; 36(3):692-700. PubMed ID: 21107310
[TBL] [Abstract][Full Text] [Related]
4. Nicotinic receptor subtypes in rat hippocampal slices are differentially sensitive to desensitization and early in vivo functional up-regulation by nicotine and to block by bupropion.
Alkondon M; Albuquerque EX
J Pharmacol Exp Ther; 2005 May; 313(2):740-50. PubMed ID: 15647329
[TBL] [Abstract][Full Text] [Related]
5. Alpha7 nicotinic acetylcholine receptors targeted by cholinergic developmental neurotoxicants: nicotine and chlorpyrifos.
Slotkin TA; Southard MC; Adam SJ; Cousins MM; Seidler FJ
Brain Res Bull; 2004 Sep; 64(3):227-35. PubMed ID: 15464859
[TBL] [Abstract][Full Text] [Related]
6. Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment.
Miksys S; Hoffmann E; Tyndale RF
Biochem Pharmacol; 2000 Jun; 59(12):1501-11. PubMed ID: 10799646
[TBL] [Abstract][Full Text] [Related]
7. Sensorimotor deficits and increased brain nicotinic acetylcholine receptors following exposure to chlorpyrifos and/or nicotine in rats.
Abou-Donia MB; Abdel-Rahman A; Goldstein LB; Dechkovskaia AM; Shah DU; Bullman SL; Khan WA
Arch Toxicol; 2003 Aug; 77(8):452-8. PubMed ID: 12937891
[TBL] [Abstract][Full Text] [Related]
8. Brain CYP2B induction can decrease nicotine levels in the brain.
Garcia KLP; Lê AD; Tyndale RF
Addict Biol; 2017 Sep; 22(5):1257-1266. PubMed ID: 27230546
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
[TBL] [Abstract][Full Text] [Related]
10. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
[TBL] [Abstract][Full Text] [Related]
11. Ethanol-induced dopamine elevation in the rat--modulatory effects by subchronic treatment with nicotinic drugs.
Löf E; Chau PP; Stomberg R; Söderpalm B
Eur J Pharmacol; 2007 Jan; 555(2-3):139-47. PubMed ID: 17141214
[TBL] [Abstract][Full Text] [Related]
12. Induction and recovery time course of rat brain CYP2E1 after nicotine treatment.
Joshi M; Tyndale RF
Drug Metab Dispos; 2006 Apr; 34(4):647-52. PubMed ID: 16434548
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment.
Ke L; Eisenhour CM; Bencherif M; Lukas RJ
J Pharmacol Exp Ther; 1998 Aug; 286(2):825-40. PubMed ID: 9694939
[TBL] [Abstract][Full Text] [Related]
14. Reparatory effects of nicotine on NMDA receptor-mediated synaptic plasticity in the hippocampal CA1 region of chronically lead-exposed rats.
Wang HL; Chen XT; Luo L; Lou ZY; Wang S; Chen JT; Wang M; Sun LG; Ruan DY
Eur J Neurosci; 2006 Mar; 23(5):1111-9. PubMed ID: 16553775
[TBL] [Abstract][Full Text] [Related]
15. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
Mousavi M; Hellström-Lindahl E
Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
[TBL] [Abstract][Full Text] [Related]
16. Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and alpha6 and beta3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat.
Visanji NP; Mitchell SN; O'Neill MJ; Duty S
Neuropharmacology; 2006 Jan; 50(1):36-46. PubMed ID: 16153666
[TBL] [Abstract][Full Text] [Related]
17. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.
Yue J; Miksys S; Hoffmann E; Tyndale RF
J Psychiatry Neurosci; 2008 Jan; 33(1):54-63. PubMed ID: 18197273
[TBL] [Abstract][Full Text] [Related]
18. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Miller DK; Sumithran SP; Dwoskin LP
J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory role of cholinergic system mediated via alpha7 nicotinic acetylcholine receptor in LPS-induced neuro-inflammation.
Tyagi E; Agrawal R; Nath C; Shukla R
Innate Immun; 2010 Feb; 16(1):3-13. PubMed ID: 19586999
[TBL] [Abstract][Full Text] [Related]
20. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
